Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trialKarim Fizazi, Mika Mustonen, John Aspegrén et al.|The Lancet Oncology|2014Cited by 194
Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical responseP. F. Morse, Annalisa Patrizi, Alessandra Bordoni et al.|British Journal of Dermatology|1989Cited by 193